论文部分内容阅读
1992年全国医药商品货源充足,价格平稳,新药走俏,医药市场仍保持较好的增长势头。1993年医药市场面临的形势是,国家指令性计划取消,商品将根据市场调节,药品专利实施,关贸总协定执行,进口药品(特别是进口制剂)、中外合资药品增长幅度将冲击我国的药品市场,对工厂企业将会带来严峻的考验。公费医疗制度的改革给医院的收入和药品使用结构方面带来一些影响。就去年全国药品供销情况来看,对1993年武汉医药市场有以下几点分析:
In 1992, there was ample supply of pharmaceutical products in the country, the prices were stable, the popularity of new drugs was very good and the pharmaceutical market still maintained a relatively good growth momentum. In the pharmaceutical market in 1993, the state ordered the cancellation of state directives. The commodities will be regulated according to the market, the implementation of drug patents, the implementation of the GATT, the import of medicines (especially imported preparations), and the growth of Sino-foreign joint-equity drugs will impact on the drugs in our country Market, the factory business will bring a severe test. The reform of the public health system has had some impact on the structure of the hospital’s income and drug use. Last year, the national drug supply and marketing situation, the pharmaceutical market in Wuhan in 1993 the following analysis: